In Vitro:Article Title: XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression.
Article Snippet: .. In Vitro Kinase Assa Purified kinase-active DCLK1 0.25 μg (cat. no., 02-139, lot. no., 15CBS-0243C; Carna Biosciences, Inc.) was incubated in kinase buffer (50 mM HEPES, pH 7.5; 0.01% Tween-20; 10 mM MgCl2; 1 mM EGTA) with 2.5 μg ULight-CREBtide peptide (cat. no., TRF0200-D; lot. no., 2427110; PerkinElmer, Inc.), 1 μM ATP (Merck KGaA), and either DMSO or XMD17-51 (the compounds were tested from 10 μM, 3-fold dilution, 10 concentration points) for 1 h at 30°C. ..
Purification:Article Title: XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression.
Article Snippet: .. In Vitro Kinase Assa Purified kinase-active DCLK1 0.25 μg (cat. no., 02-139, lot. no., 15CBS-0243C; Carna Biosciences, Inc.) was incubated in kinase buffer (50 mM HEPES, pH 7.5; 0.01% Tween-20; 10 mM MgCl2; 1 mM EGTA) with 2.5 μg ULight-CREBtide peptide (cat. no., TRF0200-D; lot. no., 2427110; PerkinElmer, Inc.), 1 μM ATP (Merck KGaA), and either DMSO or XMD17-51 (the compounds were tested from 10 μM, 3-fold dilution, 10 concentration points) for 1 h at 30°C. ..
Article Title: XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression
Article Snippet: .. Purified kinase-active DCLK1 0.25 μg (cat. no., 02-139, lot. no., 15CBS-0243C; Carna Biosciences, Inc.) was incubated in kinase buffer (50 mM HEPES, pH 7.5; 0.01% Tween-20; 10 mM MgCl 2 ; 1 mM EGTA) with 2.5 μg ULight-CREBtide peptide (cat. no., TRF0200-D; lot. no., 2427110; PerkinElmer, Inc.), 1 μM ATP (Merck KGaA), and either DMSO or XMD-17-51 (the compounds were tested from 10 μM, 3-fold dilution, 10 concentration points) for 1 h at 30°C. ..
Incubation:Article Title: XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression.
Article Snippet: .. In Vitro Kinase Assa Purified kinase-active DCLK1 0.25 μg (cat. no., 02-139, lot. no., 15CBS-0243C; Carna Biosciences, Inc.) was incubated in kinase buffer (50 mM HEPES, pH 7.5; 0.01% Tween-20; 10 mM MgCl2; 1 mM EGTA) with 2.5 μg ULight-CREBtide peptide (cat. no., TRF0200-D; lot. no., 2427110; PerkinElmer, Inc.), 1 μM ATP (Merck KGaA), and either DMSO or XMD17-51 (the compounds were tested from 10 μM, 3-fold dilution, 10 concentration points) for 1 h at 30°C. ..
Article Title: XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression
Article Snippet: .. Purified kinase-active DCLK1 0.25 μg (cat. no., 02-139, lot. no., 15CBS-0243C; Carna Biosciences, Inc.) was incubated in kinase buffer (50 mM HEPES, pH 7.5; 0.01% Tween-20; 10 mM MgCl 2 ; 1 mM EGTA) with 2.5 μg ULight-CREBtide peptide (cat. no., TRF0200-D; lot. no., 2427110; PerkinElmer, Inc.), 1 μM ATP (Merck KGaA), and either DMSO or XMD-17-51 (the compounds were tested from 10 μM, 3-fold dilution, 10 concentration points) for 1 h at 30°C. ..
Concentration Assay:Article Title: XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression.
Article Snippet: .. In Vitro Kinase Assa Purified kinase-active DCLK1 0.25 μg (cat. no., 02-139, lot. no., 15CBS-0243C; Carna Biosciences, Inc.) was incubated in kinase buffer (50 mM HEPES, pH 7.5; 0.01% Tween-20; 10 mM MgCl2; 1 mM EGTA) with 2.5 μg ULight-CREBtide peptide (cat. no., TRF0200-D; lot. no., 2427110; PerkinElmer, Inc.), 1 μM ATP (Merck KGaA), and either DMSO or XMD17-51 (the compounds were tested from 10 μM, 3-fold dilution, 10 concentration points) for 1 h at 30°C. ..
Article Title: XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression
Article Snippet: .. Purified kinase-active DCLK1 0.25 μg (cat. no., 02-139, lot. no., 15CBS-0243C; Carna Biosciences, Inc.) was incubated in kinase buffer (50 mM HEPES, pH 7.5; 0.01% Tween-20; 10 mM MgCl 2 ; 1 mM EGTA) with 2.5 μg ULight-CREBtide peptide (cat. no., TRF0200-D; lot. no., 2427110; PerkinElmer, Inc.), 1 μM ATP (Merck KGaA), and either DMSO or XMD-17-51 (the compounds were tested from 10 μM, 3-fold dilution, 10 concentration points) for 1 h at 30°C. ..
|